论文部分内容阅读
本文根据我国恶性淋巴瘤分类的修订洛阳方案对皖南地区1972-1982年336例恶性淋巴瘤进行了回顾性分析。发现其中非何杰金淋巴瘤325例(96.7％),何杰金氏病11例(3.3％)。非何杰金氏淋巴瘤中滤泡型19例(5.8％),弥漫型306例(94.2％),而弥漫型中以B细胞肿瘤(尤以滤泡中心细胞起源的肿瘤)占大多数(240例,73.8％)。T细胞肿瘤为54例(16.6％)。结果与国内各地的报告大致相同。本文还讨论了在应用修订洛阳方案进行恶性淋巴瘤分类过程中遇到的一些问题,着重指出对类型不同、大小不等起源于滤泡中心细胞的肿瘤如何结合其预后,归入适当的亚型是值得研究的问题。
This article retrospectively analyzed 336 cases of malignant lymphoma in southern Anhui from 1972 to 1982 according to the revised program of Luoyang, a classification of malignant lymphoma in our country. Among them, 325 (96.7%) non-Hodgkin’s lymphoma and 11 Hodgkin’s disease (3.3%) were found. In non-Hodgkin’s lymphoma, there were 19 follicular types (5.8%) and 306 diffuse type (94.2%), while the diffuse type included B-cell tumors (especially those with follicular center-derived cells) 240 cases, 73.8%). T cell tumors were 54 cases (16.6%). The results are roughly the same as those in other parts of the country. This article also discusses some issues encountered in the classification of malignant lymphoma using the revised Luoyang regimen, highlighting how tumors of different sizes, their origins in follicular center cells, are associated with their prognosis and classified as appropriate subtypes It is worth studying.